Literature DB >> 12708923

Fulminant adenovirus hepatitis following bone marrow transplantation. A case report and brief review of the literature.

Wei Hua Wang1, Hanlin L Wang.   

Abstract

Adenovirus infections are frequently encountered in immunocompromised patients and transplant recipients. However, fulminant hepatic failure due to adenovirus infection as a fatal complication in bone marrow transplant recipients is extremely rare. We report a case of fulminant adenovirus hepatitis in a 21-year-old allogeneic bone marrow transplant recipient who subsequently died of the disease. The diagnosis was established by histologic and immunohistochemical examination of a liver biopsy and was confirmed by liver tissue and blood cultures.

Entities:  

Mesh：

Year:  2003        PMID： 12708923     DOI： 10.5858/2003-127-e246-FAHFBM

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN： 0003-9985            Impact factor:   5.534


  14 in total

1.  Protracted course of disseminated adenovirus disease with necrotizing granulomas in the liver.

Authors:  Andrea M Lerner; John E Bennett; Stefania Pittaluga; Pavel P Khil; J H Youn; Gary A Fahle; Karen M Frank; John P Dekker; Theresa D Jerussi; Clare Sun; Adrian Wiestner; Juan Gea-Banacloche
Journal:  Diagn Microbiol Infect Dis       Date:  2019-01-02       Impact factor: 2.803

Review 2.  Current status of human adenovirus infection in China.

Authors:  Nai-Ying Mao; Zhen Zhu; Yan Zhang; Wen-Bo Xu
Journal:  World J Pediatr       Date:  2022-06-18       Impact factor: 9.186

3.  Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem cell transplant patients.

Authors:  Cedar J Fowler; Jennifer Dunlap; Darcy Troyer; Peter Stenzel; Elliot Epner; Richard T Maziarz
Journal:  Adv Hematol       Date:  2010-06-16

4.  Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton's tyrosine kinase.

Authors:  Martin L Moore; Erin L McKissic; Corrie C Brown; John E Wilkinson; Katherine R Spindler
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006.

Authors:  Gregory C Gray; Troy McCarthy; Mark G Lebeck; David P Schnurr; Kevin L Russell; Adriana E Kajon; Marie L Landry; Diane S Leland; Gregory A Storch; Christine C Ginocchio; Christine C Robinson; Gail J Demmler; Michael A Saubolle; Sue C Kehl; Rangaraj Selvarangan; Melissa B Miller; James D Chappell; Danielle M Zerr; Deanna L Kiska; Diane C Halstead; Ana W Capuano; Sharon F Setterquist; Margaret L Chorazy; Jeffrey D Dawson; Dean D Erdman
Journal:  Clin Infect Dis       Date:  2007-09-27       Impact factor: 9.079

6.  A clinical algorithm identifies high risk pediatric oncology and bone marrow transplant patients likely to benefit from treatment of adenoviral infection.

Authors:  Kirsten Marie Williams; Allison L Agwu; Alix A Dabb; Meghan A Higman; David M Loeb; Alexandra Valsamakis; Allen R Chen
Journal:  J Pediatr Hematol Oncol       Date:  2009-11       Impact factor: 1.289

Review 7.  Fulminant hepatitis due to human adenovirus.

Authors:  B A Ronan; N Agrwal; E J Carey; G De Petris; S Kusne; M T Seville; J E Blair; H R Vikram
Journal:  Infection       Date:  2013-08-24       Impact factor: 3.553

Review 8.  Hepatic complications of hematopoietic cell transplantation.

Authors:  Josh Levitsky; Michael F Sorrell
Journal:  Curr Gastroenterol Rep       Date:  2007-03

9.  Adenovirus diseases: a systematic review and meta-analysis of 228 case reports.

Authors:  Jie Gu; Qing-Qing Su; Ting-Ting Zuo; Yan-Bin Chen
Journal:  Infection       Date:  2020-07-27       Impact factor: 7.455

10.  Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome.

Authors:  M Sakai; S I Strasser; H M Shulman; S J McDonald; H G Schoch; G B McDonald
Journal:  Bone Marrow Transplant       Date:  2009-03-23       Impact factor: 5.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.